MARC

LEADER 00000cam a2200000Mi 4500
001 ocn923260596
003 OCoLC
005 20240909213021.0
006 m o d
007 cr |n|||||||||
008 151010s1900 dcu o 000 0 eng d
040 |a EBLCP  |b eng  |e pn  |c EBLCP  |d OCLCQ  |d MERUC  |d OCLCQ  |d ZCU  |d ICG  |d OCLCO  |d OCLCF  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCO  |d DKC  |d AU@  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCL 
020 |a 9780309586214 
020 |a 0309586216 
035 |a (OCoLC)923260596 
043 |a n-us--- 
050 4 |a R853.H8W66 
049 |a HCDD 
100 1 |a Staff, Institute of Medicine. 
245 1 0 |a Women and Health Research, Volume 1 :  |b Ethical and Legal Issues of Including Women in Clinical Studies. 
260 |a Washington :  |b National Academies Press,  |c 1900. 
300 |a 1 online resource (288 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
588 0 |a Print version record. 
505 0 |a ""WOMEN AND HEALTH RESEARCH""; ""Copyright""; ""Preface""; ""Acknowledgments""; ""Contents""; ""Executive Summary""; ""WOMEN'S PARTICIPATION IN CLINICAL STUDIES""; ""JUSTICE IN CLINICAL STUDIES: GUIDING PRINCIPLES""; ""SCIENTIFIC CONSIDERATIONS""; ""SOCIAL AND ETHICAL CONSIDERATIONS""; ""LEGAL CONSIDERATIONS""; ""RISKS TO REPRODUCTION AND OFFSPRING""; ""IMPLEMENTATION""; ""The Investigator""; ""Immediate Actions""; ""As Soon as Feasible""; ""The IRB""; ""Immediate Actions""; ""As Soon as Feasible""; ""IRGs and TEGs""; ""Immediate Actions""; ""As Soon as Feasible"" 
505 8 |a ""Scientific Advisory Councils""""As Soon as Feasible""; ""NIH""; ""Immediate Actions""; ""As Soon as Feasible""; ""1 Introduction""; ""MANDATE AND SCOPE OF STUDY""; ""STRUCTURE OF REPORT""; ""DEFINITIONS""; ""THE DRUG DEVELOPMENT PROCESS""; ""REFERENCES""; ""2 Women's Participation in Clinical Studies""; ""HISTORICAL BACKGROUND""; ""Evolution of Protectionist Policies""; ""Research Abuses""; ""Responses to Fetal Injury""; ""Advent of Inclusionary Policies""; ""NIH Office of Research on Women's Health and Recent Changes""; ""CURRENT STATUS""; ""Studies of Heart Disease and AIDS"" 
505 8 |a ""Heart Disease""""AIDS""; ""Women of Childbearing Age in Early Phases of Drug Trials""; ""Clinical Trial Registries""; ""CONCLUSIONS AND RECOMMENDATIONS""; ""NOTES""; ""REFERENCES""; ""3 Justice in Clinical Studies: Guiding Principles""; ""CONCEPTIONS OF JUSTICE""; ""The Distributive Paradigm""; ""Application to Clinical Studies""; ""Justice and the Research Agenda: Oppression and Power""; ""LIMITS TO THE REQUIREMENTS OF JUSTICE""; ""STATEMENT OF GUIDING PRINCIPLES""; ""REFERENCES""; ""4 Scientific Considerations""; ""EVIDENCE OF GENDER DIFFERENCES"" 
505 8 |a ""Body Size, Composition, and Metabolism""""Gender and Aging""; ""Behavioral and Psychosocial Differences""; ""Endogenous Hormones""; ""Pregnancy and Lactation""; ""Exogenous Hormones""; ""Hormonal Contraceptives""; ""Menopause and Hormone Replacement""; ""METHODOLOGICAL IMPLICATIONS""; ""Clinical Studies""; ""Clinical Trials""; ""External and Internal Validity""; ""Homogeneity Versus Heterogeneity""; ""Exclusions from Trials""; ""Subgroup Analysis""; ""Alternatives to Clinical Trials""; ""CONCLUSIONS AND RECOMMENDATIONS""; ""REFERENCES""; ""5 Social and Ethical Considerations "" 
505 8 |a ""SCIENCE AND OBJECTIVITY""""QUESTIONS OF GENDER""; ""Male Bias""; ""Male Norm""; ""QUESTIONS OF RACE AND ETHNICITY""; ""The Diversity of Women""; ""Constructions of Race and Ethnicity""; ""Biology or Sociology?""; ""Faulty Constructions of Ethnicity""; ""One Model of Health Does Not Fit All Groups""; ""Context and Meaning of Research in Different Communities""; ""RECRUITMENT AND RETENTION ISSUES""; ""Feasibility, Logistics, and Cost""; ""Outreach and Access""; ""Community Attitudes Towards Research""; ""Appropriateness of Participation""; ""PROTECTION OF RESEARCH PARTICIPANTS"" 
500 |a ""Potential for Exploitation"" 
610 1 0 |a United States.  |t National Institutes of Health Revitalization Act of 1993. 
630 0 7 |a National Institutes of Health Revitalization Act of 1993 (United States)  |2 fast 
650 0 |a Women  |x Health and hygiene  |x Research  |x Moral and ethical aspects. 
650 0 |a Human experimentation in medicine  |x Moral and ethical aspects. 
650 0 |a Human experimentation in medicine  |x Law and legislation. 
650 7 |a Human experimentation in medicine  |x Law and legislation  |2 fast 
650 7 |a Human experimentation in medicine  |x Moral and ethical aspects  |2 fast 
700 1 |a Mastroianni, Anne C. 
700 1 |a Faden, Ruth. 
758 |i has work:  |a Women and health research Volume I (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCFyFPtK9hVjrTVGVwJcRTd  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |a Staff, Institute of Medicine.  |t Women and Health Research, Volume 1 : Ethical and Legal Issues of Including Women in Clinical Studies.  |d Washington : National Academies Press, ©1900  |z 9780309049924 
856 4 0 |u https://ebookcentral.proquest.com/lib/holycrosscollege-ebooks/detail.action?docID=3376028  |y Click for online access 
903 |a EBC-AC 
994 |a 92  |b HCD